Although we have met one technical milestone, the 20 day moving average above the 100 day MA; EYES 50 day MA is still well below the 200 day MA. Because of the continued insider buying, I believe the ORION patient studies are promising. ORION opens up a new huge well defined market. When a market is this well defined and EYES is the clear worldwide leader; this stock has the potential for exponential returns. With potential exponential returns corresponding risk is always present. If ORION results are mixed or ORION fails I believe it will be a long time before we see a breakout and most likely EYES will retrace and it is back to the drawing board for Second Sight. The converse will result in exponential returns. It is a tough decision. My portfolio is substantially over-weighted with EYES. Because of this, human nature drives a bullish bias, conscious or not! Always take that into account as related to my occasional posts.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM